Mr.Ammar Ahmed Hassan Mohamed | Plastic| Best Researcher Award

Mr , Ammar Ahmed Hassan, University of Bahri College of Medicine,Sudan .

Ammar Ahmed Hassan is a distinguished academic affiliated with the University of Bahri’s College of Medicine in Sudan. His expertise spans various fields of medical science, contributing to both the academic and healthcare communities. Known for his dedication to medical education and research, Ammar plays a pivotal role in shaping the future of medicine in Sudan. His commitment to advancing knowledge and providing quality healthcare has earned him recognition in his field.

Summary:

Mr. Ammar Ahmed Hassan is suitable for the “Best Researcher Award,” I will evaluate his qualifications, professional experience, research involvement, and impact in the field of plastic and reconstructive surgery based on the information provided

Professional Profiles:

Scopus

Education :

MD of Plastic and Reconstructive Surgery (2016 – 2022),Sudan Medical Specialization Board,Specialized in plastic, reconstructive, and burn surgeries, with comprehensive training in various surgical procedures including local and regional flap surgeries.,MBBS (2007 – 2013),Omdurman Islamic University,Graduated with a GPA of 3.1/4.0. Proficient in medical knowledge and practical applications, laying the foundation for a successful career in plastic and reconstructive surgery.

Work Experience:

Head of Plastic Surgery Department (May 2023 – Present),Dongola Specialty Hospital,Established the first plastic surgery department in North Sudan, leading surgical procedures, supervising staff, and contributing to the growth of plastic surgery services in the region.,Assistant Professor of Surgery (Jan 2023 – Present),University of Bahri,Balancing clinical work with academic responsibilities, delivering lectures, supervising research, and mentoring medical students with a focus on surgical techniques and advancements.,Plastic Surgeon (May 2022 – May 2023),Bahri Burn Centre, Khartoum North Teaching Hospital,Gained extensive experience in burn and reconstructive surgeries, including hand surgeries and cleft lip and palate procedures. Managed elective and emergency operations, conducted ward rounds, and participated in clinical research.

Skills:

Surgical Expertise: Proficient in burn surgery, reconstructive hand surgery, tendon transfer, and nerve and tendon injury treatments.,Leadership: Successfully founded the first plastic surgery department in North Sudan, demonstrating strong leadership and organizational skills.,Academic Excellence: Passionate about medical education and research, with experience in delivering lectures, tutorials, and supervising exams.,Time Management: Efficient in balancing clinical duties with academic and research responsibilities.,Communication: Clear and effective communication skills, both in clinical settings and in academic environments.,Languages: Fluent in English and native in Arabic.

Research Focus:

Burn and Reconstructive Surgery: Focused on innovative techniques in burn treatment and reconstructive surgery, including hand surgery and cleft lip and palate repair.,Surgical Education: Committed to advancing surgical education through academic research and collaboration, with a focus on improving surgical outcomes and training future surgeons.

Awards and Recognitions:

Founder of the First Plastic Surgery Department in North Sudan (2023),Recognized for pioneering plastic surgery services in North Sudan and contributing to the development of healthcare in the region.

Conclusion:

Mr. Ammar Ahmed Hassan is a qualified plastic and reconstructive surgeon with a solid educational background, significant work experience, and leadership in establishing new departments. His academic role as an assistant professor indicates active involvement in research and education. However, to fully assess his suitability for the “Best Researcher Award,” more detailed information on his specific research contributions, publications, and impact is needed. If Mr. Ammar has made significant contributions through research, especially in the area of plastic and reconstructive surgery, he could be a strong candidate for the award.

Publications :

 

  • Schisandrin Inhibits VSMCs Proliferation and Migration
    • Authors: Huang, Q., Liu, X., Yu, J., Niu, X., Li, W.
    • Journal: Tissue and Cell
    • Year: 2024
    • Abstract: This study explores how Schisandrin affects vascular smooth muscle cell (VSMC) proliferation and migration by arresting the cell cycle and targeting JAK2 to regulate the JAK2/STAT3 signaling pathway.

 

  • Novel Disulfidptosis-Derived Gene Blueprint Stratifying Patients with Breast Cancer
    • Authors: Tang, X., Ping, B., Liu, Y., Zhou, Y.
    • Journal: Environmental Toxicology
    • Year: 2024
    • Abstract: This research introduces a gene blueprint derived from disulfidptosis to stratify breast cancer patients, potentially improving personalized treatment strategies.

 

  • Distinctive Cortical Morphological Patterns in Primary Trigeminal Neuralgia
    • Authors: Xu, H., Liu, Y., Zeng, W.-T., Fan, Y.-X., Wang, Y.
    • Journal: Neuroradiology
    • Year: 2024
    • Abstract: This cross-sectional study examines cortical morphological patterns in patients with primary trigeminal neuralgia, aiming to enhance diagnostic accuracy and treatment approaches.

 

  • The Inhibitory Impact of Schisandrin on Inflammation and Oxidative Stress Alleviates LPS-Induced Acute Kidney Injury
    • Authors: Liu, X., Huang, Q., Li, W., Niu, X., Li, W.
    • Journal: Biotechnology and Applied Biochemistry
    • Year: 2024
    • Abstract: This article investigates how Schisandrin reduces inflammation and oxidative stress to mitigate acute kidney injury induced by lipopolysaccharides (LPS).

 

  • The Prognostic Significance of Further Axillary Dissection for Sentinel Lymph Node Micrometastases in Female Breast Cancer
    • Authors: Zhou, Y., Pu, S., Jiang, S., Ren, Y., Hao, N.
    • Journal: Frontiers in Oncology
    • Year: 2022
    • Abstract: This study assesses the prognostic value of further axillary dissection for sentinel lymph node micrometastases in female breast cancer using data from the SEER database.

 

  • Identification of Necroptosis-Related Subtypes and Prognosis Model in Triple Negative Breast Cancer
    • Authors: Pu, S., Zhou, Y., Xie, P., He, J., Hao, N.
    • Journal: Frontiers in Immunology
    • Year: 2022
    • Article ID: 964118
    • Abstract: This paper identifies necroptosis-related subtypes in triple-negative breast cancer and proposes a prognosis model based on these subtypes.

 

  • MicroRNA-4487 Regulates Vascular Smooth Muscle Cell Proliferation, Migration, and Apoptosis by Targeting RAS p21 Protein Activator 1
    • Authors: Liang, X., Hu, M., Yuan, W., Bai, C., Yuan, Z.
    • Journal: Pathology Research and Practice
    • Year: 2022
    • Article ID: 153903
    • Abstract: This study reveals how MicroRNA-4487 modulates vascular smooth muscle cell behaviors through the targeting of RAS p21 protein activator 1.

 

  • Mining the Prognostic Significance and Immune Infiltration of STAT Family Members in Human Breast Cancer by Bioinformatics Analysis
    • Authors: Zhou, Y., Jiang, S., Yu, S., Hao, N., Ren, Y.
    • Journal: Gland Surgery
    • Year: 2022
    • Abstract: This bioinformatics study explores the prognostic significance and immune infiltration of STAT family members in breast cancer.

 

  • Ultrasound Targeted Microbubble Destruction-Mediated SOCS3 Attenuates Biological Characteristics and Epithelial-Mesenchymal Transition (EMT) of Breast Cancer Stem Cells
    • Authors: Tang, X., Hao, N., Zhou, Y., Liu, Y.
    • Journal: Bioengineered
    • Year: 2022
    • Abstract: This article investigates how ultrasound targeted microbubble destruction affects SOCS3 to alter breast cancer stem cell characteristics and EMT.

 

  • Bacteriophage Twort Protein Gp168 is a Ī²-Clamp Inhibitor by Occupying the DNA Sliding Channel
    • Authors: Liu, B., Li, S., Liu, Y., Wang, Y., Zhang, K.
    • Journal: Nucleic Acids Research
    • Year: 2021
    • Abstract: This study details how the Twort bacteriophage protein Gp168 functions as a Ī²-clamp inhibitor by binding to the DNA sliding channel.
Ammar Ahmed Hassan Mohamed | Plastic| Best Researcher Award

You May Also Like